Cargando…
The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
BACKGROUND: Proton pump inhibitors (PPIs) are among the most commonly used medications by patients due to its availability over the counter and frequent prescribing by physicians to treat and alleviate symptoms of gastroesophageal reflux disease. Recently, the FDA issued a warning with respect to th...
Autores principales: | Tawam, Dania, Baladi, Michael, Jungsuwadee, Paiboon, Earl, Grace, Han, Jayoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102963/ https://www.ncbi.nlm.nih.gov/pubmed/34007671 http://dx.doi.org/10.24926/iip.v12i1.3439 |
Ejemplares similares
-
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021) -
Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007) -
Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients
por: Pohl, John F., et al.
Publicado: (2011) -
Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017) -
Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
por: Bradley, Evan Stuart, et al.
Publicado: (2019)